APHA
APHA
Stocks
APHA
APHA
Stocks
Since 2013, we have built the foundation for a leading global company, with cultivation, manufacturing, research and distribution infrastructure, as well as strategic investments and alliances to scale around the world.
Aphria's strong momentum, outlook and options as a premier global cannabis company promise significant long-term value for shareholders.
Learn everything you need to start your investment with us today.
A printed version of the Company’s financial statements is available upon request. Please email Aphria Inc. Investor Relations at investors@aphria.com to request a free copy.
Q2 FY21 Financial Statements
Q2 FY21 MD&A
Q1 FY21 Financial Statements
Q1 FY21 MD&A
Q4 FY20 Financial Statements
Q4 FY20 MD&A
Q3 FY20 Financial Statements
Q3 FY20 MD&A
Q2 FY20 Financial Statements
Q2 FY20 MD&A
Q1 FY20 Financial Statements
Q1 FY20 MD&A
Annual Report
Notice of Meeting and Management Information Circular
Form of Proxy
Q4 FY19 Financial Statements
Q4 FY19 MD&A
Q4 FY19 XBRL
Q3 FY19 Financial Statements
Q3 FY19 MD&A
Q2 FY19 Financial Statements
Q2 FY19 MD&A
Q1 FY19 Financial Statements
Q1 FY19 MD&A
Annual Report
Management Information Circular
Q4 FY18 Financial Statements
Q4 2018 MD&A
Q3 FY18 Financial Statements
Q3 FY18 MD&A
Q2 FY18 Financial Statements
Q2 FY18 MD&A
Q1 FY18 Financial Statements
Q1 FY18 MD&A
Annual Report
Management Information Circular
Q4 FY17 Financial Statements
Q4 FY17 MD&A
Q3 FY17 Financial Statements
Q3 FY17 MD&A
Q2 FY17 Financial Statements
Q2 FY17 MD&A
Q1 FY17 Financial Statements
Q1 FY17 MD&A
Annual Report
Management Information Circular
Q4 FY16 Financial Statements
Q4 FY16 MD&A
Q3 FY16 MD&A
Q2 FY16 Financial Statements
Q2 FY16 MD&A
Q1 FY16 Financial Statements
Q1 FY16 MD&A
Annual Report
Management Information Circular
Q4 FY15 Financial Statements
Q4 FY15 MD&A
Q3 FY15 Financial Statements
Q3 FY15 MD&A
Q2 FY15 Financial Statements
Aphria and Tilray Investor Presentation (December 2020)
Agreement to Acquire Sweetwater Brewing Company
To request printed copies of our disclosure information please either call 1-844-427-4742 or email investors@aphria.com
Upcoming Events
To view press releases, please click here.
Form of Proxy
15/10/2020
Management information circular
15/10/2020
Notice of Meeting
15/10/2020
Other
15/10/2020
Other
15/10/2020
52-109F2 - CEO certification of interim filings - CEO (E)
15/10/2020
52-109F2 - CFO certification of interim filings - CFO (E)
15/10/2020
MD&A
15/10/2020
Interim financial statements/report
15/10/2020
Notice of the meeting and record date (amended) - English
02/10/2020
Material Change Report
04/08/2020
Q1 FY20 MD&A
15/10/2019
Q1 FY20 Interim Consolidated Financial Statements
15/10/2019
Other material contracts - English
01/10/2019
Notice of the meeting and record date - English
09/09/2019
Decision Document (Preliminary)
23/08/2019
Preliminary Short Form Prospectus - English
23/08/2019
Qualification Certificate
23/08/2019
FY19 - 52-109F1 - Certification of Annual Filings - CEO (E)
01/08/2019
FY19 - 52-109F1 - Certification of Annual Filings - CFO (E)
01/08/2019
AB Form 13-501F1 (Class 1 and 3B Reporting Issuers - Participation Fee)
01/08/2019
FY 19 Annual Information Form - English
01/08/2019
MD&A - English
01/08/2019
ON Form 13-502F1 (Class 1 and 3B Reporting Issuers - Participation Fee)
01/08/2019
FY 19 Audited Annual Financial Statements - English
01/08/2019
Material Change Report - English
22/05/2019
Documents affecting rights of securityholders - Trust indentures re debt
08/05/2019
Other Securityholders Documents - English
08/05/2019
Report of Exempt Distribution Excluding Schedule 1 of 45-106F1
02/05/2019
Material Change Report - English
29/04/2019
Q3 FY19 52-109F2 - Certification of Interim Filings - CEO (E)
15/04/2019
Q3 FY19 52-109F2 - Certification of Interim Filings - CFO (E)
15/04/2019
Q3 FY19 Interim Financial Statements - English
15/04/2019
Q3 FY19 MD&A - English
15/04/2019
Notice of Change or Variation - English
15/04/2019
Notice of Change or Variation - French
15/04/2019
View EDGAR releases below.
6-K
Report of foreign issuer
15/10/2020
6-K
Report of foreign issuer
15/10/2019
6-K
Report of foreign issuer
15/10/2019
6-K
Report of foreign issuer
15/10/2019
6-K
Report of foreign issuer
08/10/2019
6-K
Report of foreign issuer
01/10/2019
6-K
Report of foreign issuer
24/09/2019
6-K
Report of foreign issuer
05/09/2019
40-F/A
[Amend] Registration statement [Section 12] or Annual Report
26/08/2019
6-K
Report of foreign issuer
23/08/2019
F-X
Appointment of Agent for Service of Process and Undertaking
23/08/2019
F-10
Registration Statement for Securities of certain Canadian Issuers.
23/08/2019
40-F
Registration statement or Annual Report
01/08/2019
6-K
Report of foreign issuer
01/08/2019
6-K
Report of foreign issuer
29/07/2019
6-K
Report of foreign issuer
18/07/2019
6-K
Report of foreign issuer
08/07/2019
6-K
Report of foreign issuer
14/06/2019
6-K
Report of foreign issuer
07/06/2019
6-K
Report of foreign issuer
21/05/2019
6-K
Report of foreign issuer
14/05/2019
6-K
Report of foreign issuer
01/05/2019
6-K
Report of foreign issuer
01/05/2019
SC14D1F/A
[Amend] Tender Offer Statement
26/04/2019
425
Prospectuses and communications, business combinations
26/04/2019
6-K
Report of foreign issuer
24/04/2019
6-K
Report of foreign issuer
18/04/2019
6-K
Report of foreign issuer
18/04/2019
6-K
Report of foreign issuer
17/04/2019
SC14D1F/A
[Amend] Tender Offer Statement
16/04/2019
425
Prospectuses and communications, business combinations
16/04/2019
6-K
Report of foreign issuer
15/04/2019
6-K
Report of foreign issuer
15/04/2019
6-K
Report of foreign issuer
15/04/2019
6-K
Report of foreign issuer
05/04/2019
6-K
Report of foreign issuer
01/04/2019
6-K
Report of foreign issuer
28/03/2019
6-K
Report of foreign issuer
04/03/2019
6-K
Report of foreign issuer
04/03/2019
6-K
Report of foreign issuer
28/02/2019
6-K
Report of foreign issuer
20/02/2019
6-K
Report of foreign issuer
20/02/2019
6-K
Report of foreign issuer
08/02/2019
425
Prospectuses and communications, business combinations
07/02/2019
6-K
Report of foreign issuer
06/02/2019
6-K
Report of foreign issuer
01/02/2019
425
Prospectuses and communications, business combinations
23/01/2019
6-K
Report of foreign issuer
23/01/2019
425
Prospectuses and communications, business combinations
23/01/2019
6-K
Report of foreign issuer
18/01/2019
6-K
Report of foreign issuer
14/01/2019
6-K
Report of foreign issuer
11/01/2019
6-K
Report of foreign issuer
09/01/2019
6-K
Report of foreign issuer
09/01/2019
425
Prospectuses and communications, business combinations
03/01/2019
425
Prospectuses and communications, business combinations
03/01/2019
6-K
Report of foreign issuer
02/01/2019
6-K
Report of foreign issuer
28/12/2018
6-K
Report of foreign issuer
27/12/2018
6-K
Report of foreign issuer
24/12/2018
6-K
Report of foreign issuer
21/12/2018
6-K
Report of foreign issuer
21/12/2018
6-K
Report of foreign issuer
19/12/2018
6-K
Report of foreign issuer
12/12/2018
6-K
Report of foreign issuer
06/12/2018
6-K
Report of foreign issuer
06/12/2018
6-K
Report of foreign issuer
03/12/2018
6-K
Report of foreign issuer
08/11/2018
6-K
Report of foreign issuer
07/11/2018
6-K
Report of foreign issuer
05/11/2018
6-K
Report of foreign issuer
30/10/2018
CERT
Acc-no: 0000876661-18-001127 (34 Act)
24/10/2018
F-X
Appointment of Agent for Service of Process and Undertaking
18/10/2018
40FR12B
Registration of a Class of Securities of certain Canadian issuers
18/10/2018
Firm
Analyst
Phone Number
Email Address
Upcoming Events
Past Events
Second Quarter 2021 Results
Aphria executives will host a conference call on January 14, 2021 at 9:00 am EST to discuss second quarter financial results.
January 14, 2021
View DetailsAphria and Tilray | Conference Call
Aphria and Tilray to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time
December 16, 2020
View DetailsWounded Warriors | The Wellness Lounge Featuring Shea Emry
Canada’s Veterans, First Responders and their family and friends are invited to attend The Wellness Lounge – an online conversation to promote community, connections and wellness.
November 24, 2020
View DetailsJefferies Virtual London Healthcare Conference
Aphria management will host a fireside chat discussion at the Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020 at 9:05 a.m. ET.
November 18, 2020
View DetailsMandate of the Board of Directors
Mandate of the Chair of Board
Mandate of the Lead Director
Charter of the Audit Committee
Mandate of the Chair of the Audit Committee
Charter of the Compensation Committee
Mandate of the Chair of the Compensation Committee
Charter of the Nominating and Governance Committee
Mandate of the Chair of the Nominating and Governance Committee
Nasdaq Statement of Governance Differences
By-Laws and Advance Notice Policy
Majority Voting Policy
Certificate and Articles of Amalgamation
Code of Conduct and Ethics
Corporate Disclosure Charter
Whistleblower Policy
Anti-Corruption and Anti-Bribery Compliance Policy
To make investing in us as easy as possible, please find our specific investment details below.
Common Share Listings
Toronto Stock Exchange (TSX - primary) & National Association of Securities Dealers Automated Quotations (Nasdaq)
Trading Symbol
APHA
Shares Outstanding
316,793,160
Transfer Agent
Computershare Trust Company of Canada.
100 University Ave, 8th Floor
Toronto, Ontario, Canada M5J 2Y1
Phone
Auditors
PriceWaterhouseCoopers, LLP
Head Office Address
PO Box 20009 269 Erie St South
Leamington, Ontario, Canada N8H 3C4
CUSIP Number
03765K
NAICS Code
325412
GICS Code
35202010
The more you know about investing with us, the more you will have to look forward to.
Aphria Inc. is traded on the Toronto Stock Exchange (TSX) and the National Association of Securities Dealers Automated Quotations (NASDAQ) under the trading symbol “APHA”. Individuals interested in buying or selling Aphria’s shares should contact their financial institution or investment advisor.
Aphria Inc.’s fiscal year starts on June 1st and ends on May 31st
Quarterly and year-end financial reports can be accessed on our investors webpage in the financial filings section. You may also view these reports, along with other statutory filings, through SEDAR.com (Can) or EDGAR.com (U.S).
Computershare Trust Company of Canada is Aphria Inc.’s transfer agent. They can be contacted at: Computershare Trust Company of Canada 100 University Ave, 8th Floor Toronto, ON M5J 2Y1 Phone: 1-888-453-0330
The Transfer Agent can help investors change details concerning the ownership of their shares including registering a name change or a change of address. They can also help if the original share certificate is lost.
Aphria’s auditor is Price Waterhouse Coopers.
You can join our investor email list for corporate updates by following this link and clicking the “Sign Up” button at the top of the page. After completing all the required fields, you will be sent a confirmation email in your inbox. You can also keep informed of company and industry development by following our social media outlets: Twitter, LinkedIn, YouTube.